Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2384)
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,567
Price
$6.24
Total Value
$103.38K
Shares Held After
1,226,607
% of Holdings
1.3%
Oscar Health, Inc. (OSCR)
Blackley Richard Scott — Chief Financial Officer
Shares
19,221
Price
$13.39
Total Value
$257.37K
Shares Held After
1,466,660
% of Holdings
1.3%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
1,660
Price
$9.95
Total Value
$16.52K
Shares Held After
148,777
% of Holdings
1.1%
908 Devices Inc. (MASS)
McCallion Kevin J. — SVP, Products and Production
Shares
7
Price
$7.00
Total Value
$49.00
Shares Held After
44,918
% of Holdings
0.0%
10x Genomics, Inc. (TXG)
Saxonov Serge — Director
Shares
1,860
Price
$23.18
Total Value
$43.11K
Shares Held After
1,203,667
% of Holdings
0.2%
10x Genomics, Inc. (TXG)
Saxonov Serge — Director
Shares
14,292
Price
$22.67
Total Value
$323.99K
Shares Held After
1,205,527
% of Holdings
1.2%
Stoke Therapeutics, Inc. (STOK)
Krainer Adrian R. — Director
Shares
7,229
Price
$39.66
Total Value
$286.72K
Shares Held After
316,545
% of Holdings
2.2%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
24,335
Price
$13.39
Total Value
$325.85K
Shares Held After
514,986
% of Holdings
4.5%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
42
Price
$203.57
Total Value
$8.55K
Shares Held After
42,720
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
50
Price
$202.54
Total Value
$10.13K
Shares Held After
42,762
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
83
Price
$201.65
Total Value
$16.74K
Shares Held After
42,812
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
41
Price
$200.40
Total Value
$8.22K
Shares Held After
42,895
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
204
Price
$199.69
Total Value
$40.74K
Shares Held After
42,936
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
47
Price
$197.14
Total Value
$9.27K
Shares Held After
43,140
% of Holdings
0.1%
LifeStance Health Group, Inc. (LFST)
BLACK DARREN M. — Director
Shares
4,314,939
Price
$7.01
Total Value
$30.25M
Shares Held After
29,209,776
% of Holdings
12.9%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
12,532
Price
$9.95
Total Value
$124.69K
Shares Held After
198,981
% of Holdings
5.9%
FibroBiologics, Inc. (FBLG)
O'HEERON PETE — Director
Shares
17,428
Price
$0.35
Total Value
$6.15K
Shares Held After
5,924,075
% of Holdings
0.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Leonard Keith R — Director
Shares
39,272
Price
$25.39
Total Value
$997.19K
Shares Held After
22,123
% of Holdings
64.0%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
1,442
Price
$5.09
Total Value
$7.34K
Shares Held After
61,978
% of Holdings
2.3%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
1,298
Price
$5.09
Total Value
$6.60K
Shares Held After
63,420
% of Holdings
2.0%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
58
Price
$5.08
Total Value
$294.64
Shares Held After
64,718
% of Holdings
0.1%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
198
Price
$5.08
Total Value
$1.01K
Shares Held After
64,776
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
892
Price
$495.96
Total Value
$442.40K
Shares Held After
22,811
% of Holdings
3.8%
LifeStance Health Group, Inc. (LFST)
TPG GP A, LLC — 10% Owner
Shares
20,685,061
Price
$7.01
Total Value
$145.00M
Shares Held After
140,026,557
% of Holdings
12.9%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific & Med Officer
Shares
13,425
Price
$36.16
Total Value
$485.43K
Shares Held After
117,346
% of Holdings
10.3%
ANI PHARMACEUTICALS INC (ANIP)
Mutz Christopher — HEAD OF RARE DISEASE
Shares
417
Price
$74.00
Total Value
$30.86K
Shares Held After
103,508
% of Holdings
0.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$25.65
Total Value
$256.52K
Shares Held After
49,744
% of Holdings
16.7%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$29.72
Total Value
$267.49K
Shares Held After
89,389
% of Holdings
9.1%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
7,132
Price
$2.60
Total Value
$18.54K
Shares Held After
203,040
% of Holdings
3.4%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$29.29
Total Value
$59.58K
Shares Held After
237,660
% of Holdings
0.8%
Vericel Corp (VCEL)
Halpin Michael — Chief Operating Officer
Shares
10,305
Price
$35.30
Total Value
$363.77K
Shares Held After
16,080
% of Holdings
39.1%
QUEST DIAGNOSTICS INC (DGX)
Davis J. E. — Director
Shares
10,000
Price
$212.52
Total Value
$2.13M
Shares Held After
117,185
% of Holdings
7.9%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
5,714
Price
$45.92
Total Value
$262.39K
Shares Held After
61,324
% of Holdings
8.5%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
22,223
Price
$44.88
Total Value
$997.37K
Shares Held After
67,038
% of Holdings
24.9%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
12,063
Price
$44.20
Total Value
$533.18K
Shares Held After
89,261
% of Holdings
11.9%
Tempus AI, Inc. (TEM)
Rogers James William — Chief Financial Officer
Shares
11,414
Price
$50.69
Total Value
$578.58K
Shares Held After
127,248
% of Holdings
8.2%
Vanda Pharmaceuticals Inc. (VNDA)
Polymeropoulos Mihael Hristos — Director
Shares
156,235
Price
$8.17
Total Value
$1.28M
Shares Held After
2,704,496
% of Holdings
5.5%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$35.36
Total Value
$530.40K
Shares Held After
1,262
% of Holdings
92.2%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
6,421
Price
$34.75
Total Value
$223.13K
Shares Held After
1,262
% of Holdings
83.6%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
100
Price
$10.83
Total Value
$1.08K
Shares Held After
21,906
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Shares
2,911
Price
$1.43
Total Value
$4.16K
Shares Held After
365,734
% of Holdings
0.8%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Shares
1,861
Price
$1.43
Total Value
$2.66K
Shares Held After
368,645
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Shares
2,125
Price
$1.43
Total Value
$3.04K
Shares Held After
370,506
% of Holdings
0.6%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Shares
835
Price
$1.43
Total Value
$1.19K
Shares Held After
372,631
% of Holdings
0.2%
Vanda Pharmaceuticals Inc. (VNDA)
Birznieks Gunther — SVP, Business Development
Shares
42,431
Price
$8.27
Total Value
$350.73K
Shares Held After
494,197
% of Holdings
7.9%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Smethurst Dominic — Chief Medical Officer
Shares
6,097
Price
$8.30
Total Value
$50.60K
Shares Held After
89,790
% of Holdings
6.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
583
Price
$47.01
Total Value
$27.41K
Shares Held After
45,761
% of Holdings
1.3%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,292
Price
$46.67
Total Value
$60.30K
Shares Held After
46,344
% of Holdings
2.7%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
10,429
Price
$47.01
Total Value
$490.31K
Shares Held After
98,748
% of Holdings
9.6%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
22,487
Price
$46.67
Total Value
$1.05M
Shares Held After
109,177
% of Holdings
17.1%
Showing 2151–2200 of 2384 transactions (page 44 of 48)